In the latter role, Guy was a critical part of the team that applied for and received a total investment of AUD 140 million over 7 years to establish and operate Australia???s first translational drug discovery and development organization to produce pre-clinical drug candidates to treat cancer, Cancer Therapeutics CRC Pty Ltd, under the Federal Australian government???s CRC grant scheme.